Is the pneumonia vaccine recommended for asthmatics or smokers ages 19-64?

The recommendation for the pneumonia vaccine for individuals with asthma or those who smoke is based on the increased risk these groups have for developing pneumonia and experiencing complications from respiratory infections. Both asthma and smoking can impair lung function and reduce the immune system's ability to respond effectively to infections.

Therefore, it is advisable for individuals aged 19-64 who have asthma or are smokers to receive the pneumonia vaccine. The pneumococcal vaccine helps provide protection against pneumococcal pneumonia, which can lead to severe illness, hospitalization, and is more common in individuals with compromised respiratory health.

Vaccination is a critical preventive measure in these populations to reduce the incidence of pneumonia and the associated morbidity and mortality. By ensuring that both asthmatics and smokers are vaccinated, healthcare providers can significantly improve health outcomes within these at-risk groups.